MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/coc.0b013e3181dbbafe

Медицинская библиотека · American journal of clinical oncology · 2011

Chemoradiation for esophageal cancer: institutional experience with three different regimens.

Courrech Staal Ewout F W, Aleman Berthe M P, van Velthuysen Marie-Louise F, Cats Annemieke, Boot Henk, Jansen Edwin P M, van Coevorden Frits, van Sandick Johanna W

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

The aim of this study was to retrospectively evaluate toxicity and efficacy of 3 chemoradiation regimens.

METHODS

Between 1997 and 2007, 94 patients with esophageal cancer were treated with chemoradiation in our institute. Treatment consisted of radiotherapy to 50 Gy in 25 fractions with concurrent cisplatin and 5-fluorouracil (group A, n = 65), radiotherapy to 50.4 Gy in 28 fractions with concurrent carboplatin and paclitaxel (group B, n = 16) or radiotherapy to 66 Gy in 33 fractions with low-dose cisplatin (group C, n = 13). Toxicity was scored according to Common Terminology Criteria version 3.0.

RESULTS

Chemoradiation was planned as neoadjuvant (n = 58) or definitive (n = 36) treatment. Grade 3/4 hematological toxicity occurred in 18 (19%) patients and grade 3 nonhematologic toxicity in 8 (9%) patients. During treatment, 2 patients died (1 from duodenal ulcer bleeding and 1 from stroke). Overall, 81 (86%) patients completed the planned treatment (86%, 94%, and 77% in groups A, B, and C, respectively). Clinically complete or partial response was observed in 28 of 92 (30%) patients (21%, 50%, and 54% in groups A, B, and C, respectively). After clinical and radiologic response evaluation, treatment plan was changed in 14 (15%) patients. A total of 45 patients underwent surgery. Pathologic complete response and downstaging were seen in 12 (27%) and 34 (76%) operated patients, respectively. With a median follow-up of 15 (range, 1-108) months, the 3-year survival was 41% for all patients.

CONCLUSION

With individual treatment planning, different regimens of chemoradiation for esophageal cancer resulted in acceptable rates of toxicity and efficacy.

Для цитирования: Courrech Staal Ewout F W, Aleman Berthe M P, van Velthuysen Marie-Louise F, Cats Annemieke, Boot Henk, Jansen Edwin P M, van Coevorden Frits, van Sandick Johanna W. Chemoradiation for esophageal cancer: institutional experience with three different regimens.. American journal of clinical oncology. 2011. DOI: 10.1097/coc.0b013e3181dbbafe.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.